Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy

Cancer

Volumn 88, Issue 9, 2000, Pages 2189-2193

  Reddy, Alyssa T ^a,d   Janss, Anna J ^b   Phillips, Peter C ^b   Weiss, Heidi L ^a   Packer, Roger J ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d CHILDREN S HOSPITAL OF ALABAMA   (United States)

Author keywords

Chemotherapy; Pineoblastoma; Primitive neuroectodermal tumors arising supratentorially (SPNET); Radiation; Supratentorial primitive neuroectodermal; Tumor

Indexed keywords

CISPLATIN; LOMUSTINE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BRAIN CORTEX; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEUROECTODERM TUMOR; PINEAL BODY; PRIORITY JOURNAL; SKULL IRRADIATION; SURVIVAL RATE; THALAMUS; TREATMENT OUTCOME; TUMOR BIOPSY;

ADOLESCENT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CEREBRAL CORTEX; CHILD; CHILD, PRESCHOOL; CISPLATIN; CRANIAL IRRADIATION; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; LINEAR MODELS; LOMUSTINE; NEOPLASM STAGING; NEUROECTODERMAL TUMORS, PRIMITIVE; PINEALOMA; RETROSPECTIVE STUDIES; SUPRATENTORIAL NEOPLASMS; SURVIVAL RATE; THALAMIC DISEASES; TREATMENT OUTCOME; VINCRISTINE;

EID: 0034192270     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000501)88:9<2189::AID-CNCR27>3.0.CO;2-G     Document Type: Article

References (9)

1. Gaffney CC, Sloan, JP, Bradley NJ, Bloom HJ. Primitive neuroectodermal tumours of the cerebrum. Pathology and treatment. J Neurooncol 1985;3:23-33.
2. Bruno RL, Norris DG. Primitive neruoectodermal tumors of infancy and childhood. In: Humphrey GB, Dehner LP, Grindey GB, editors. Pediatric oncology. vol. 1. Boston: Nijhoff, 1981:265-7.
3. Dirks PB, Harris L, Hoffman HJ, Humphreys RP, Drake JM, Rutka JT. Supratentorial primitive neuroectodermal tumors in children. J Neurooncol 1996;29:75-84.
4. Packer RJ, Sutton LN, Elterman R, Lange B, Goldwein J, Nicholson HS, et al. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 1994;81:690-8.
5. Cohen BH, Zeltzer PM, Boyett JM, Geyer JR, Allen JC, Finlay, et al. Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Children's Cancer Group randomized trial. J Clin Oncol 1995;13:1687-96.
6. Yang HJ, Nam DH, Wang KC, Kim YM, Chi JG, Cho BK. Supratentorial primitive neuroectodermal tumor in children: clinical features, treatment outcome and prognostic factors. Childs Nerv Syst 1999;15:377-83.
7. Burnett ME, White EC, Sih S, von Haken MS, Cogen PH. Chromosome arm 17p deletion analysis reveals molecular genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the central nervous system. Cancer Genet Cytogenet 1997;97:25-31.
8. Moriuchi S, Shimizu K, Miyao Y, Hayakawa T. An immunohistochemical analysis of medulloblastoma and PNET with emphasis on N-myc protein expression. Anticancer Res 1996;16:2687-92.
9. Russo C, Pellarin M, Tingby O, Bollen AW, Lamborn KR, Mohapatra G, et al. Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors. Cancer 1999;86:331-9.